Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

651
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
651
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

594
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
594
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

614
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
614
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

771
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
771
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

812
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
812
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

1.5K
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy and Safety of Esketamine in Total Hip and Knee Arthroplasty: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Cureus·2026
Same author

The Role of Experimental Animal Models in Liver Transplantation Training Programs.

Biomedicines·2026
Same author

The decline of vitamin D in adolescent athletes: insights from a one-year follow-up and its association with electrocardiographic changes.

Frontiers in cardiovascular medicine·2025
Same author

Pharmacology and Therapeutic Potential of Finerenone: A Novel Third-Generation Nonsteroidal Mineralocorticoid Receptor Antagonist.

Cureus·2025
Same author

Behçet's Disease and the Burden of Chronicity: Interplay Between Physical Symptoms, Mental Health, and Quality of Life.

Cureus·2025
Same author

A case report of complex acute coronary syndrome presentation: Plaque rupture and mild coronary artery ectasia presenting as de Winter T-waves morphing into anterior ST-elevation myocardial infarction in a young adult male.

SAGE open medical case reports·2025

Related Experiment Video

Updated: Apr 21, 2026

Author Spotlight: Investigating HR-Dependent Cardiac Function in Mouse Models Through a Novel Atrial-Pacing Approach
07:49

Author Spotlight: Investigating HR-Dependent Cardiac Function in Mouse Models Through a Novel Atrial-Pacing Approach

Published on: July 21, 2023

2.1K

State-of-the-Art Strategies in Heart Failure Screening.

Mahmoud M Ramadan1,2, Abdelrahman Nouh1, Hamza Haj-Mohamed1

  • 1Department of Clinical Sciences, College of Medicine, University of Sharjah, Sharjah 27272, United Arab Emirates.

Current Cardiology Reviews
|April 20, 2026
PubMed
Summary

Early heart failure (HF) screening in high-risk individuals using biomarkers and imaging can improve outcomes. Integrated screening frameworks with digital support show promise for timely diagnosis and intervention.

Keywords:
Heart failureNT-proBNPartificial intelligencedigital healthearly detectionpersonalized medicine.screening strategiestelemedicine

More Related Videos

Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients
03:47

Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients

Published on: July 12, 2024

1.3K
Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
09:20

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction

Published on: February 13, 2021

7.2K

Related Experiment Videos

Last Updated: Apr 21, 2026

Author Spotlight: Investigating HR-Dependent Cardiac Function in Mouse Models Through a Novel Atrial-Pacing Approach
07:49

Author Spotlight: Investigating HR-Dependent Cardiac Function in Mouse Models Through a Novel Atrial-Pacing Approach

Published on: July 21, 2023

2.1K
Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients
03:47

Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients

Published on: July 12, 2024

1.3K
Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
09:20

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction

Published on: February 13, 2021

7.2K

Area of Science:

  • Cardiology and Public Health
  • Diagnostic Strategies
  • Digital Health Integration

Background:

  • Heart failure (HF) affects millions globally, with late diagnosis leading to preventable morbidity.
  • Early, asymptomatic stages are often missed, delaying critical interventions.
  • Effective screening is crucial for early detection and disease modification.

Purpose of the Study:

  • To review current literature on heart failure screening strategies.
  • To evaluate the diagnostic performance and feasibility of various screening methods.
  • To identify gaps and future directions for HF screening implementation.

Main Methods:

  • Narrative review of PubMed and Embase (2018-2025) focusing on HF screening.
  • Inclusion of studies on biomarkers, imaging, digital health, and AI.
  • Synthesis of findings on diagnostic accuracy, feasibility, and implementation.

Main Results:

  • Targeted screening of high-risk groups is more effective than symptom-based approaches.
  • Natriuretic peptides (BNP/NT-proBNP) are sensitive for ruling out HF and for biomarker triage.
  • Echocardiography is key for structural/functional assessment; digital tools show promise for risk stratification and monitoring.

Conclusions:

  • Gaps exist in outcome-driven trials, screening pathway standardization, and access to diagnostics.
  • Digital/AI approaches require addressing data quality, privacy, bias, and workflow integration.
  • Integrated, stepwise screening frameworks with digital support can enhance early HF detection and care linkage.